Get started
Author

Taizo Shimomura

Distinct Roles of Ephrin-B2 Forward and EphB4 Reverse Signaling in Endothelial Cells
2003 · Koichi Hamada, Yuichi Oike, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 87
Analysis of a Chronic Myelogenous Leukemia Patient Vaccinated with Leukemic Dendritic Cells Following Autologous Peripheral Blood Stem Cell Transplantation
1999 · Shin‐ichiro Fujii, Kanako Shimizu, et al. · Japanese Journal of Cancer Research · 56
IDH 1 and IDH 2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM 1 mutation
2014 · Shunichiro Yamaguchi, Eisaku Iwanaga, et al. · European Journal Of Haematology · 52
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system
2010 · Tetsuzo Tauchi, Masahiro Kizaki, et al. · Leukemia Research · 40
High frequency of IKZF1 genetic alterations in adult patients with B ‐cell acute lymphoblastic leukemia
2013 · Kenji Tokunaga, Shunichiro Yamaguchi, et al. · European Journal Of Haematology · 36
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia
2009 · Hitoshi Suzushima, Naoko Wada, et al. · Leukemia Research · 20
Activated Dendritic Cells From Bone Marrow Cells of Mice Receiving Cytokine-Expressing Tumor Cells Are Associated With the Enhanced Survival of Mice Bearing Syngeneic Tumors
1999 · Shin-ichiro Fujii, Hirofumi Hamada, et al. · Blood · 19
Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan
2016 · Katsuto Takenaka, Kazuya Shimoda, et al. · International Journal of Hematology · 18
A spindle cell variant of diffuse large B‐cell lymphoma is characterized by T‐cell/myofibrohistio‐rich stromal alterations: analysis of 10 cases and a review of the literature
2012 · Yoshizo Kimura, Fumiko Arakawa, et al. · European Journal Of Haematology · 16
IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation
2013 · Shunichiro Yamaguchi, Eisaku Iwanaga, et al. · Blood · 12
Current and future perspectives on the TARGET system: the registration system for Glivec® established by the JSH
2008 · and the TARGET Investigators, Masahiro Kizaki, et al. · International Journal of Hematology · 12
Endomucin Is Expressed in Embryonic Dorsal Aorta and Is Able to Inhibit Cell Adhesion
2001 · Masaya Ueno, Katsuhide Igarashi, et al. · Biochemical and Biophysical Research Communications · 11
Galectin-9 as a Predictive Marker for the Onset of Immune-Related Adverse Effects Associated with Anti-CCR4 MoAb Therapy in Patients with Adult T Cell Leukemia
2017 · Tareg Omer Mohammed, Haorile Chagan-Yasutan, et al. · The Tohoku Journal of Experimental Medicine · 8
PDF
Phase 1/2 Study of the Activin Receptor-like Kinase-2 Inhibitor Zilurgisertib (INCB000928, LIMBER-104) As Monotherapy or with Ruxolitinib in Patients with Anemia Due to Myelofibrosis
2023 · Sanjay Mohan, Stephen Oh, et al. · Blood · 7
Phase 1/2 study of the activin receptor-like kinase (ALK)-2 inhibitor zilurgisertib (INCB000928, LIMBER-104) as monotherapy or with ruxolitinib (RUX) in patients (pts) with anemia due to myelofibrosis (MF).
2023 · Prithviraj Bose, Sanjay Mohan, et al. · Journal of Clinical Oncology · 5
PDF
Systemic Lupus Erythematosus-associated Acute Acalculous Cholecystitis Successfully Treated by a Corticosteroid Combined with Azathioprine
2019 · Noritaka Kudo, Hirokazu Takaoka, et al. · Internal Medicine · 5
PDF
Thrombopoietin stimulates murine lineage negative, Sca-1+, C-Kit+, CD34- cells: comparative study with stem cell factor or interleukin-3.
2000 · T Shimomura, Y Yonemura, et al. · PubMed · 4
Characterization of T-cell receptor beta chain mRNA expression in IFN-alpha-responsive chronic myelogenous leukaemia patients
1999 · Taizo Shimomura, Shin-ichiro Fujii, et al. · British Journal of Haematology · 4
PDF
P1022: Phase 1/2 Study of the Activin Receptor-like Kinase 2 (alk2) Inhibitor Zilurgisertib (incb000928, Limber-104) as Monotherapy or With Ruxolitinib in Patients With Anemia Due to Myelofibrosis
2023 · Prithviraj Bose, Sanjay Mohan, et al. · HemaSphere · 2
The activin receptor-like kinase-2 inhibitor zilurgisertib (INCB000928) as monotherapy or with ruxolitinib in patients with anemia due to myelofibrosis: Phase 1/2 study final results
2025 · Prithviraj Bose, Stephen Oh, et al. · Blood · 1
PDF
Rheumatoid arthritis caused by non-tuberculous mycobacteria infection
2022 · Hirokazu Takaoka, Taizo Shimomura, et al. · Modern Rheumatology Case Reports · 1
Accumulation Of Gene Alterations Of TP53, Crebbp and IKZF1 Is a Prognostic Factor In Adult Acute Lymphoblastic Leukemia
2013 · Kenji Tokunaga, Shunichro Yamaguchi, et al. · Blood · 1
Role of Random Skin Biopsies in the Diagnosis of Aortic Angiosarcoma
2025 · Tomohiro Miyamura, Ken Yoshida, et al. · Internal Medicine
PDF
Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study
2024 · Saki Ogawa, Kotaro Shide, et al. · Blood
PDF
POSTER: MPN-548 Phase I/II Study of the Activin Receptor-like Kinase 2 (ALK2) Inhibitor Zilurgisertib (INCB000928, LIMBER-104) as Monotherapy or With Ruxolitinib in Patients With Anemia Due to Myelofibrosis
2023 · Prithviraj Bose, Sanjay Mohan, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 31
Citation count: 417
H-index: 11
I10-index: 12
Year
Topic
Type